This Kidney International review addressed the safety of kidney-preserving medications during breastfeeding, providing practical guidance for CKD women on which cardiovascular and renal therapies are compatible with lactation.
Breastfeeding has recognized health benefits for all mother-infant dyads, which are particularly important for women with chronic kidney disease (CKD) and their children. There is growing evidence to suggest breastfeeding positively impacts maternal vascular health by lowering blood pressure, assisting with weight loss, improving lipid profiles, and preventing type 2 diabetes. Similarly, breastfed infants have demonstrated decreased risks of developing obesity, hypertension, and diabetes, improving their long-term vascular health.
